Literature DB >> 19127076

Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient.

Lorenzo Calligaris1, Gabriele Stocco, Sara De Iudicibus, Sara Marino, Giuliana Decorti, Egidio Barbi, Marco Carrozzi, Federico Marchetti, Fiora Bartoli, Alessandro Ventura.   

Abstract

A case of severe hypersensitivity syndrome, triggered by carbamazepine in the presence of a concomitant active human herpes virus (HHV) 6 and 7 infection is described. To further understand the molecular mechanism of this adverse reaction, analyses of the genetic variants of human leukocyte antigen (HLA) and of the epoxide hydrolase gene (EPHX1), previously associated with carbamazepine hypersensitivity, were performed. A lymphocyte transformation test (LTT) was conducted in order to detect drug-specific lymphocytes. In the hypersensitive patient, 2 genetic factors previously associated with intolerance to carbamazepine were detected: the allele HLA-A*3101 and homozygosity for the variant allele of SNP rs1051740 in EPHX1. Drug-specific lymphocytes could be detected by LTT when the HHV was active (positive PCR for viral DNA and increased anti-HHV 6 IgG titer), but not when it was no longer active. In conclusion, we document a case of severe carbamazepine hypersensitivity triggered by viral reactivation in a patient presenting the interaction of 2 unfavorable genetic factors. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19127076     DOI: 10.1159/000189202

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  2 in total

1.  Genetic predisposition to oxcarbazepine induced Stevens-Johnson syndrome.

Authors:  Pranay Wal; Ankita Wal; Umeshwar Pandey; Awani K Rai; Anil Bhandari
Journal:  Indian J Crit Care Med       Date:  2011-07

2.  The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

Authors:  Joshua C Pritchett; Radu M Nanau; Manuela G Neuman
Journal:  Int J Hepatol       Date:  2012-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.